Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...
Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.
Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.
This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.
UnitedHealth Group slid after The Wall Street Journal reported that the Department of Justice was probing the insurance giant's Medicare billing practices. The company, which had already faced a ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Dr. Alexandra Sowa, an obesity medicine specialist and author of the new book “The Ozempic Revolution” shares the pros ... coverage of anti-obesity medications for Americans with Medicare and Medicaid ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...
The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Insurers also ask the Trump administration, which is engaged in a sweeping campaign to eradicate anything related to ...